View of A real-world, retrospective, observational study to evaluate the safety and effectiveness of Fulvestrant (Eranfu) monotherapy in HR+/HER2- advanced breast cancer patients

Return to Article Details A real-world, retrospective, observational study to evaluate the safety and effectiveness of Fulvestrant (Eranfu) monotherapy in HR+/HER2- advanced breast cancer patients Download Download PDF